BEUDAMED
    252 results · 21ms · Sources: EU EUDAMED, US FDA
    Filters Classification: FDA Class 2 ×

    SOLAR GI

    FDA 510(k)
    FDA Class 2 ·Gastroenterology, Urology

    Hsv-1 And Hsv-2 Cns Nucleic-Acid Based Panel

    FDA classification
    FDA Class 2 ·Hsv-1 And Hsv-2 Cns Nucleic-Acid Based Panel

    Multiplex Immunoassay For T. Gondii, Rubella, Cytomegalovirus And Herpes Simplex Virus 1 And 2

    FDA classification
    FDA Class 2 ·Multiplex Immunoassay For T. Gondii, Rubella, Cytomegalovirus And Herpes Simplex Virus 1 And 2

    Peripheral Intravenous (Piv) Infiltration Monitor

    FDA classification
    FDA Class 2 ·Peripheral Intravenous (Piv) Infiltration Monitor

    Herpes Simplex Virus Nucleic Acid Amplification Assay

    FDA classification
    FDA Class 2 ·Herpes Simplex Virus Nucleic Acid Amplification Assay

    System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi)

    FDA classification
    FDA Class 2 ·System,Test,Antibodies,B2 - Glycoprotein I (B2 - Gpi)

    Insufflator, Endoscopic Vessel Harvesting

    FDA classification
    FDA Class 2 ·Insufflator, Endoscopic Vessel Harvesting

    Pacing System Analyzer

    FDA classification
    FDA Class 2 ·Pacing System Analyzer

    Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-1

    FDA classification
    FDA Class 2 ·Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-1

    Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-2

    FDA classification
    FDA Class 2 ·Enzyme Linked Immunosorbent Assay, Herpes Simplex Virus, Hsv-2

    Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

    FDA classification
    FDA Class 2 ·Prostate-Specific Antigen (Psa) For Management Of Prostate Cancers

    Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers

    FDA classification
    FDA Class 2 ·Prostate-Specific Antigen (Psa) For Prognostic, Recurrence Risk Assessment Of Prostate Cancers